Skip to main content
Top
Published in: Tumor Biology 4/2013

01-08-2013 | Research Article

Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population

Authors: Shan Zhong, Wei Zhao, Chaojing Lu, Bailing Li, Yang Yuan, Danfeng Guo, Zhijie Chang, Binhua Jiao, Lixin Yang

Published in: Tumor Biology | Issue 4/2013

Login to get access

Abstract

Glutathione S-transferases (GSTs) play important roles in the detoxification of electrophilic carcinogens, and GSTM1 null genotype is associated with the dysfunction of GSTs. Previous studies investigating the association between GSTM1 null genotype and risk of esophageal carcinoma in Chinese provided inconsistent findings. To provide a more precise estimation on the association between GSTM1 null genotype and risk of esophageal carcinoma in Chinese population, a meta-analysis was performed. Eligible studies were searched in PubMed, Embase, and China National Knowledge Infrastructure databases. Odds ratio (OR) with the corresponding 95 % confidence interval (95 %CI) was used to assess the association. A total of 18 case–control studies involving 1,947 cases and 3,506 controls were finally included in the meta-analysis. Meta-analysis of those 18 studies showed that GSTM1 null genotype was associated with an increased risk of esophageal carcinoma in Chinese (random effect model OR = 1.49, 95 %CI = 1.11–2.00, P = 0.008). The findings from cumulative meta-analysis showed that the association was more obvious as the data increased by publication year. There was no risk of publication bias in the meta-analysis. Therefore, the findings from our meta-analysis provide a strong evidence for the association between GSTM1 null genotype and risk of esophageal carcinoma in Chinese population, and GSTM1 null genotype contributes to increased risk of esophageal carcinoma in Chinese.
Literature
1.
go back to reference Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9:278–87.PubMedCrossRef Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol. 2012;9:278–87.PubMedCrossRef
2.
3.
go back to reference Denlinger CE, Thompson RK. Molecular basis of esophageal cancer development and progression. Surg Clin North Am. 2012;92:1089–103.PubMedCrossRef Denlinger CE, Thompson RK. Molecular basis of esophageal cancer development and progression. Surg Clin North Am. 2012;92:1089–103.PubMedCrossRef
4.
go back to reference Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, et al. Consensus statements for management of barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a delphi process. Gastroenterology. 2012;143:336–46.PubMedCrossRef Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, et al. Consensus statements for management of barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a delphi process. Gastroenterology. 2012;143:336–46.PubMedCrossRef
5.
go back to reference Tejani MA, Burtness BA. Multi-modality therapy for cancer of the esophagus and ge junction. Curr Treat Options in Oncol. 2012;13:390–402.CrossRef Tejani MA, Burtness BA. Multi-modality therapy for cancer of the esophagus and ge junction. Curr Treat Options in Oncol. 2012;13:390–402.CrossRef
6.
go back to reference Di Pietro G, Magno LA, Rios-Santos F. Glutathione s-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 2010;6:153–70.PubMedCrossRef Di Pietro G, Magno LA, Rios-Santos F. Glutathione s-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol. 2010;6:153–70.PubMedCrossRef
7.
go back to reference Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev. 2009;12:389–439.PubMedCrossRef Ginsberg G, Smolenski S, Hattis D, Guyton KZ, Johns DO, Sonawane B. Genetic polymorphism in glutathione transferases (GST): population distribution of GSTM1, T1, and P1 conjugating activity. J Toxicol Environ Health B Crit Rev. 2009;12:389–439.PubMedCrossRef
8.
go back to reference Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:103–16.PubMedCrossRef Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:103–16.PubMedCrossRef
9.
go back to reference Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.PubMedCrossRef Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, et al. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508–18.PubMedCrossRef
10.
go back to reference Zhang Y, Liu C. The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population. Tumour Biol. 2013;34:395–401.PubMedCrossRef Zhang Y, Liu C. The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population. Tumour Biol. 2013;34:395–401.PubMedCrossRef
11.
go back to reference Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev. 1998;7:1013–8.PubMed Lin DX, Tang YM, Peng Q, Lu SX, Ambrosone CB, Kadlubar FF. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev. 1998;7:1013–8.PubMed
12.
go back to reference Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, et al. Impact of genetic polymorphisms in cytochrome p450 2e1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev. 2000;9:551–6.PubMed Tan W, Song N, Wang GQ, Liu Q, Tang HJ, Kadlubar FF, et al. Impact of genetic polymorphisms in cytochrome p450 2e1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev. 2000;9:551–6.PubMed
13.
go back to reference Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case–control study of a high-incidence area in Jiangsu Province, China. Cancer Lett. 2002;188:95–102.PubMedCrossRef Gao CM, Takezaki T, Wu JZ, Li ZY, Liu YT, Li SP, et al. Glutathione-S-transferases M1 (GSTM1) and GSTT1 genotype, smoking, consumption of alcohol and tea and risk of esophageal and stomach cancers: a case–control study of a high-incidence area in Jiangsu Province, China. Cancer Lett. 2002;188:95–102.PubMedCrossRef
14.
go back to reference Roth MJ, Abnet CC, Johnson LL, Mark SD, Dong ZW, Taylor PR, et al. Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control. 2004;15:1077–83.PubMedCrossRef Roth MJ, Abnet CC, Johnson LL, Mark SD, Dong ZW, Taylor PR, et al. Polymorphic variation of Cyp1A1 is associated with the risk of gastric cardia cancer: a prospective case-cohort study of cytochrome P-450 1A1 and GST enzymes. Cancer Causes Control. 2004;15:1077–83.PubMedCrossRef
15.
go back to reference Wang AH, Sun CS, Li LS, Huang JY, Chen QS, Xu DZ. Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. World J Gastroenterol. 2004;10:940–4.PubMed Wang AH, Sun CS, Li LS, Huang JY, Chen QS, Xu DZ. Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. World J Gastroenterol. 2004;10:940–4.PubMed
16.
go back to reference Lu XM, Zhang YM, Lin RY, Arzi G, Wang X, Zhang YL, et al. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol. 2005;11:3651–4.PubMed Lu XM, Zhang YM, Lin RY, Arzi G, Wang X, Zhang YL, et al. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol. 2005;11:3651–4.PubMed
17.
go back to reference Dong C, Wu J, Jin Y, Zhang J. Correlation between genetic polymorphism of CYP2E1, GSTM1 and esophageal cancer in Gansu. Chin J Gastroenterol Hepatol. 2007;16:115–8. Dong C, Wu J, Jin Y, Zhang J. Correlation between genetic polymorphism of CYP2E1, GSTM1 and esophageal cancer in Gansu. Chin J Gastroenterol Hepatol. 2007;16:115–8.
18.
go back to reference Liu R, Yin L, Pu Y, Li Y, Liang G, Zhang J, et al. Functional alterations in the glutathione S-transferase family associated with enhanced occurrence of esophageal carcinoma in China. J Toxicol Environ Health A. 2010;73:471–82.PubMedCrossRef Liu R, Yin L, Pu Y, Li Y, Liang G, Zhang J, et al. Functional alterations in the glutathione S-transferase family associated with enhanced occurrence of esophageal carcinoma in China. J Toxicol Environ Health A. 2010;73:471–82.PubMedCrossRef
19.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRef
20.
21.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
22.
go back to reference Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRef
23.
go back to reference Shao G, Su Y, Huang G, Wen B. Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2000;21:420–3.PubMed Shao G, Su Y, Huang G, Wen B. Relationship between CYP1A1, GSTM1 genetic polymorphisms and susceptibility to esophageal squamous cell carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2000;21:420–3.PubMed
24.
go back to reference Shi Y, Zhou X, Zhou Y, Ren S. Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technol (Heal Sci). 2002;31:14–7. Shi Y, Zhou X, Zhou Y, Ren S. Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technol (Heal Sci). 2002;31:14–7.
25.
go back to reference Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTS and MEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China. World J Gastroenterol. 2003;9:1394–7.PubMed Wang LD, Zheng S, Liu B, Zhou JX, Li YJ, Li JX. CYP1A1, GSTS and MEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high- incidence area in north China. World J Gastroenterol. 2003;9:1394–7.PubMed
26.
go back to reference Han Y, Feng X, Li P, Niu Z. Case–control study on relationship of CYP1A1 and GSTM1 polymorphisms and susceptibility to esophageal squamous carcinoma. Chin J Public Health. 2005;21:3–6. Han Y, Feng X, Li P, Niu Z. Case–control study on relationship of CYP1A1 and GSTM1 polymorphisms and susceptibility to esophageal squamous carcinoma. Chin J Public Health. 2005;21:3–6.
27.
go back to reference Yi L, Pu Y, Song Y, Hu X, Liu Y, Kai H. Polymorphisms of susceptible genes for esophageal cancer risk in Huaian population in Jiangsu Province. Tumor. 2005;25:357–61. Yi L, Pu Y, Song Y, Hu X, Liu Y, Kai H. Polymorphisms of susceptible genes for esophageal cancer risk in Huaian population in Jiangsu Province. Tumor. 2005;25:357–61.
28.
go back to reference Lu XM, Yang T, Xu SY, Wen H, Wang X, Ren ZH, et al. Glutathione-S-transferase M1 polymorphisms on the susceptibility to esophageal cancer among three Chinese minorities: Kazakh, Tajik and Uygur. World J Gastroenterol. 2006;12:7758–61.PubMed Lu XM, Yang T, Xu SY, Wen H, Wang X, Ren ZH, et al. Glutathione-S-transferase M1 polymorphisms on the susceptibility to esophageal cancer among three Chinese minorities: Kazakh, Tajik and Uygur. World J Gastroenterol. 2006;12:7758–61.PubMed
29.
go back to reference Li Y, Zhu WC, Lin Z, Wu H, Ye Z. Correlation between smoking and the polymorphism of gene GSTM1 and esophageal carcinoma. Heilongjiang Med J. 2008;32:18–20. Li Y, Zhu WC, Lin Z, Wu H, Ye Z. Correlation between smoking and the polymorphism of gene GSTM1 and esophageal carcinoma. Heilongjiang Med J. 2008;32:18–20.
30.
go back to reference Ji R, Wu J, Zhou Y, Zhang B, Zhang Z, Yang Z. Relationship between CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility of esophageal cancer in Wuwei, Gansu Province. J Lanzhou Univ (Med Sci). 2010;36:29–34. Ji R, Wu J, Zhou Y, Zhang B, Zhang Z, Yang Z. Relationship between CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility of esophageal cancer in Wuwei, Gansu Province. J Lanzhou Univ (Med Sci). 2010;36:29–34.
31.
go back to reference Chen Y, Zhang H, Yi D, Wang H, Wang Y, Deng Y, Ma Y: Relationship between GSTM1 gene polymorphism and interaction of gene environment and susceptibility of esophageal cancer. Modern Preventive Medicine 2012;39:1235–9. Chen Y, Zhang H, Yi D, Wang H, Wang Y, Deng Y, Ma Y: Relationship between GSTM1 gene polymorphism and interaction of gene environment and susceptibility of esophageal cancer. Modern Preventive Medicine 2012;39:1235–9.
32.
go back to reference Gao P, Qian Y, Ye X, Ge J, Zang D, Xu W. Study of CTPIA1, GSTT1, GSTM1 polymorphisms and susceptibility on esophageal carcinoma in Ningxia Hui nationality. Ningxia Med J. 2012;34:196–9. Gao P, Qian Y, Ye X, Ge J, Zang D, Xu W. Study of CTPIA1, GSTT1, GSTM1 polymorphisms and susceptibility on esophageal carcinoma in Ningxia Hui nationality. Ningxia Med J. 2012;34:196–9.
33.
go back to reference Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, Lu X. Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol. 2011;23:1087–99.PubMedCrossRef Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, Lu X. Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol. 2011;23:1087–99.PubMedCrossRef
34.
go back to reference Jana S, Mandlekar S. Role of phase II drug metabolizing enzymes in cancer chemoprevention. Curr Drug Metab. 2009;10:595–616.PubMedCrossRef Jana S, Mandlekar S. Role of phase II drug metabolizing enzymes in cancer chemoprevention. Curr Drug Metab. 2009;10:595–616.PubMedCrossRef
Metadata
Title
Glutathione S-transferase M1 null genotype contributes to increased risk of esophageal carcinoma in Chinese population
Authors
Shan Zhong
Wei Zhao
Chaojing Lu
Bailing Li
Yang Yuan
Danfeng Guo
Zhijie Chang
Binhua Jiao
Lixin Yang
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0790-3

Other articles of this Issue 4/2013

Tumor Biology 4/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine